ThinkEquity LLC

17 State Street, 41st Floor

New York, NY 10004

 

March 23, 2023

 

VIA EDGAR

 

U.S. Securities and Exchange Commission

Division of Corporate Finance

100 F St., NE

Washington, D.C. 20549

 

  Re: Altamira Therapeutics Ltd.
    Withdrawal of Request for Acceleration
    Registration Statement on Form F-1 (File No. 333-269823)

 

Ladies and Gentlemen:

 

On March 17, 2023, ThinkEquity LLC, as representative of the underwriters, requested acceleration of the effective date of the above-referenced Registration Statement so that it would become effective at 5:00PM on Tuesday, March 21, 2023 or as soon thereafter as practicable. We hereby withdraw such request.

 

  Very truly yours,
     
  ThinkEquity LLC
     
  By: /s/ Eric Lord
  Name:  Eric Lord
  Title: Head of Investment Banking